LILIAN DANA: Open Payments
NPI 1922641448 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 29 payments from 14 companies in 2025. Trend: 2023 $98 · 2024 $408 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 4 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Calliditas Therapeutics US Inc. | 2 | $52 |
| Amgen Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Vifor Pharma, Inc. | 2 | $38 |
| Fresenius USA Marketing, Inc. | 2 | $37 |
| Apellis Pharmaceuticals, Inc. | 1 | $32 |
| Travere Therapeutics, Inc. | 1 | $25 |
Products named: PURIFIED CORTROPHIN GEL, Kerendia, TARPEYO, Veltassa, VELPHORO, LOKELMA, Empaveli, TAVNEOS.
Industry payments across UT — which companies pay providers there.
